Repligen
RGEN
#2702
Rank
NZ$11.08 B
Marketcap
NZ$196.55
Share price
1.49%
Change (1 day)
-3.85%
Change (1 year)
Categories

Market capitalization of Repligen (RGEN)

Market cap: NZ$11.08 Billion

As of May 2026 Repligen has a market cap of NZ$11.08 Billion. This makes Repligen the world's 2702th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Repligen from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$11.08 B-31.37%
2025NZ$16.15 B11.73%
2024NZ$14.45 B-8.92%
2023NZ$15.87 B7.21%
2022NZ$14.80 B-30.93%
2021NZ$21.43 B47.52%
2020NZ$14.53 B103.17%
2019NZ$7.15 B107.14%
2018NZ$3.45 B55.16%
2017NZ$2.22 B47.84%
2016NZ$1.50 B10.53%
2015NZ$1.36 B64.44%
2014NZ$0.82 B56.29%
2013NZ$0.52 B122.52%
2012NZ$0.23 B74.38%
2011NZ$0.13 B-27.04%
2010NZ$0.18 B7.52%
2009NZ$0.17 B-14.3%
2008NZ$0.20 B-23.51%
2007NZ$0.26 B119.11%
2006NZ$0.12 B-31.23%
2005NZ$0.17 B45.18%
2004NZ$0.12 B-39.69%
2003NZ$0.20 B26.74%
2002NZ$0.15 B1.61%
2001NZ$0.15 B-22.81%
2000NZ$0.20 B51.69%
1999NZ$0.13 B205.04%
1998NZ$43.75 M80.61%
1997NZ$24.22 M-9.4%
1996NZ$26.74 M

End of Day market cap according to different sources

On May 25th, 2026 the market cap of Repligen was reported to be:

NZ$11.08 Billion
by Nasdaq info icon info icon
NZ$11.08 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$252.15 B 2,174.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$284.56 B 2,466.77%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$540.50 B 4,775.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$207.41 B 1,770.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$0.12 B-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$2.58 B-76.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$26.91 B 142.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$12.89 B 16.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$17.85 B 61.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
NZ$13.18 B 18.97%๐Ÿ‡บ๐Ÿ‡ธ USA